Teva Pharmaceutical Q1 2025 Earnings Preview

Posted on by wpadmin
  • Teva Pharmaceutical (NYSE:TEVA) is scheduled to announce Q1 earnings results on Wednesday, May 7th, before market open.
  • The consensus EPS Estimate is $0.46 (-4.2% Y/Y) and the consensus Revenue Estimate is $3.99B (+4.5% Y/Y).
  • Over the last 2 years, TEVA

Leave a Reply

Your email address will not be published. Required fields are marked *